| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.189 | 21.255 | 23.397 | 22.933 | 826 | 5.229 | 10.723 | 7.410 | 5.888 | 5.224 |
| Total Income - EUR | 17.189 | 21.255 | 23.397 | 22.933 | 4.619 | 5.229 | 10.723 | 7.410 | 5.888 | 5.224 |
| Total Expenses - EUR | 17.723 | 18.250 | 23.077 | 22.268 | 5.011 | 246 | 207 | 711 | 766 | 1.372 |
| Gross Profit/Loss - EUR | -533 | 3.005 | 320 | 666 | -391 | 4.982 | 10.516 | 6.698 | 5.122 | 3.852 |
| Net Profit/Loss - EUR | -1.049 | 2.792 | 86 | 436 | -530 | 4.829 | 10.233 | 6.482 | 4.500 | 3.322 |
| Employees | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cyrrussmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.915 | 5.989 | 5.046 | 4.128 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 732 | 2.260 | 739 | 425 | 56 | 5.007 | 12.058 | 17.562 | 8.172 | 7.927 |
| Inventories | 14 | 22 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.287 | 6.575 | 3.725 |
| Cash | 718 | 2.238 | 724 | 425 | 56 | 5.007 | 12.058 | 11.276 | 1.597 | 4.202 |
| Shareholders Funds | 33 | 2.825 | 165 | 598 | 56 | 4.884 | 12.029 | 9.970 | 8.172 | 7.869 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 7.613 | 5.424 | 5.621 | 3.956 | 0 | 122 | 29 | 7.592 | 0 | 57 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cyrrussmed S.r.l.